Growth Metrics

Disc Medicine (IRON) Accounts Payables (2020 - 2026)

Disc Medicine (IRON) reported Accounts Payables of $11.8 million for Q1 2026, up 75.43% year-over-year from $6.7 million in Q1 2025, and up 30.39% on a QoQ basis from $9.0 million in Q4 2025.

Disc Medicine (IRON) has 7 years of Accounts Payables data on file, last reported at $11.8 million in Q1 2026.

  • Quarterly Accounts Payables rose 75.43% year-over-year to $11.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 million (up 75.43% YoY) and the FY2025 annual result came in at $9.0 million, up 13.46% from the prior year.
  • Accounts Payables rose to $11.8 million in Q1 2026 per IRON's latest filing, from $9.0 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $16.2 million in Q4 2022 and bottomed at $1.1 million in Q3 2022.
  • The 5-year median for Accounts Payables is $6.4 million (2025), against an average of $7.0 million.
  • The widest annual swing landed in 2023, when Accounts Payables soared 645.92%; it then tumbled 58.18% in 2024.
  • Tracing IRON's Accounts Payables over 5 years: stood at $16.2 million in 2022, then decreased by 21.86% to $12.6 million in 2023, then tumbled by 37.07% to $7.9 million in 2024, then gained by 13.46% to $9.0 million in 2025, then soared by 30.39% to $11.8 million in 2026.
  • Per Business Quant, the three latest IRON Accounts Payables figures stand at $11.8 million (Q1 2026), $9.0 million (Q4 2025), and $7.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.05 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 10.62 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 8.64 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 489.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.03 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 126.63 Mn
10 Disc Medicine 2.76 Bn 2.03 Bn - 11.76 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.76 Mn
Dec 31, 2025 9.02 Mn
Sep 30, 2025 7.27 Mn
Jun 30, 2025 6.35 Mn
Mar 31, 2025 6.70 Mn
Dec 31, 2024 7.95 Mn
Sep 30, 2024 3.55 Mn
Jun 30, 2024 4.75 Mn
Mar 31, 2024 5.27 Mn
Dec 31, 2023 12.63 Mn
Sep 30, 2023 8.50 Mn
Jun 30, 2023 5.21 Mn
Mar 31, 2023 5.64 Mn
Dec 31, 2022 16.16 Mn
Sep 30, 2022 1.14 Mn
Jun 30, 2022 1.62 Mn
Mar 31, 2022 5.11 Mn
Dec 31, 2021 2.56 Mn
Sep 30, 2021 939,000.00
Jun 30, 2021 1.49 Mn
Mar 31, 2021 3.56 Mn
Dec 31, 2020 2.38 Mn
Sep 30, 2020 40,489.00